The cytoplasmic domain of the F protein of Human respiratory syncytial virus is not required for cell fusion

References

1. Arumugham R. G., Seid R. C. Jr, Doyle S., Hildreth S. W., Paradiso P. R. 1989; Fatty acid acylation of the fusion glycoprotein of human respiratory syncytial virus. J Biol Chem 264:10339–10342
   [Google Scholar]
2. Bhattacharya J., Peters P. J., Clapham P. R. 2004; Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. J Virol 78:5500–5506 [CrossRef]
   [Google Scholar]
3. Bolt G., Pedersen L. O., Birkeslund H. H. 2000; Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin. Virus Res 68:25–33 [CrossRef]
   [Google Scholar]
4. Branigan P. J., Liu C., Day N. D., Gutshall L. L., Sarisky R. T., Del Vecchio A. M. 2005; Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein. Virol J 2:54 [CrossRef]
   [Google Scholar]
5. Brown G., Jeffree C. E., McDonald T., Rixon H. W. McL., Aitken J. D., Sugrue R. J. 2004; Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection. Virology 327:175–185 [CrossRef]
   [Google Scholar]
6. Collins P. L., Mottet G. 1991; Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol 72:3095–3101 [CrossRef]
   [Google Scholar]
7. Colman P. M., Lawrence M. C. 2003; The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol 4:309–319 [CrossRef]
   [Google Scholar]
8. Dolganuic V., Mc Ginnes L., Luna E. J., Morrison T. G. 2003; Role of the cytoplasmic domain of the Newcastle disease virus fusion protein in association with lipid rafts. J Virol 77:12968–12979 [CrossRef]
   [Google Scholar]
9. Gharpure M. A., Wright P. F., Chanock R. M. 1969; Temperature-sensitive mutants of respiratory syncytial virus. J Virol 3:414–421
   [Google Scholar]
10. Gonzalez-Reyes L., Ruiz-Arguello M. B., Garcia-Barreno B., Calder L., López J. A., Albar J. P., Skehel J. J., Wiley D. C., Melero J. A. 2001; Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A 98:9859–9864 [CrossRef]
    [Google Scholar]
11. Gruber C., Levine S. 1983; Respiratory syncytial virus polypeptides. III. The envelope-associated proteins. J Gen Virol 64:825–832 [CrossRef]
    [Google Scholar]
12. Han L. L., Alexander J. P., Anderson L. J. 1999; Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 179:25–30 [CrossRef]
    [Google Scholar]
13. Hsu K.-H. L., Crowe J. E. Jr, Lubeck M. D., Davis A. R., Hung P. P., Chanock R. M., Murphy B. R. 1995; Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus. Vaccine 13:509–515 [CrossRef]
    [Google Scholar]
14. Ison M. G., Hayden F. G. 2002; Viral infections in immunocompromised patients: what's new with respiratory viruses?. Curr Opin Infect Dis 15:355–367 [CrossRef]
    [Google Scholar]
15. Johnson S., Oliver C., Prince G. A. & 13 other authors 1997; Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis 176:1215–1224 [CrossRef]
    [Google Scholar]
16. Lamb R. A., Kolakofsky D. 2001; Paramyxoviridae : the viruses and their replication. In Fields Virology , 4th edn. pp  1305–1340 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott, Williams & Wilkins;
    [Google Scholar]
17. Long D., Cohen G. H., Muggeridge M. I., Eisenberg R. J. 1990; Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function. J Virol 64:5542–5552
    [Google Scholar]
18. Morton C. J., Cameron R., Lawrence L. J. & 11 other authors 2003; Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay. Virology 311:275–288 [CrossRef]
    [Google Scholar]
19. Rixon H. W. McL., Brown C., Brown G., Sugrue R. J. 2002; Multiple glycosylated forms of the respiratory syncytial virus fusion protein are expressed in virus-infected cells. J Gen Virol 83:61–66
    [Google Scholar]
20. Scheid A., Choppin R. W. 1977; Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology 80:54–66 [CrossRef]
    [Google Scholar]
21. Sergel T., Morrison T. G. 1995; Mutations in the cytoplasmic domain of the fusion glycoprotein of Newcastle disease virus depress syncytia formation. Virology 210:264–272 [CrossRef]
    [Google Scholar]
22. Smith B. J., Lawrence M. C., Colman P. M. 2002; Modelling the structure of the fusion protein from human respiratory syncytial virus. Protein Eng 15:365–371 [CrossRef]
    [Google Scholar]
23. Thompson W. W., Shay D. K., Weintraub E., Brammer L., Cox N., Anderson L. J., Fukuda K. 2003; Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179–186 [CrossRef]
    [Google Scholar]
24. Whimbey E., Ghosh S. 2000; Respiratory syncytial virus infections in immunocompromised adults. Curr Clin Top Infect Dis 20:232–255
    [Google Scholar]